Who owns the AVERITAS PHARMA trademark?

The AVERITAS PHARMA trademark is owned by Averitas Pharma, Inc..

What is the serial number for AVERITAS PHARMA?

The USPTO serial number for AVERITAS PHARMA is 88091437.

What is the registration number for AVERITAS PHARMA?

AVERITAS PHARMA is registered under USPTO registration number 0.

AVE

USPTO Trademark Record

ABANDONED

AVERITAS PHARMA

Q: What class is the AVERITAS PHARMA trademark registered in?

The AVERITAS PHARMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 041 (Education & entertainment services), Class 042 (Scientific, technology & SaaS services).

SN 88091437·Reg 0·Filed Aug 24, 2018

Owner Averitas Pharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Education; providing of training; entertainment; sporting and cultural activities.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AVERITAS PHARMA (Serial No. 88091437), Registration No. 0, is a abandoned US trademark filed on Aug 24, 2018 by Averitas Pharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 041 (Education & entertainment services), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

AVERITAS PHARMA (Reg. #0) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 041 (Education & entertainment services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 24, 2018

SERIAL

88091437

REG#

Owner

Applicant

Averitas Pharma, Inc.

Entity

Corporation

State

Address

360 Mount Kemble Ave., Morristown, NJ, 07960

Country

Attorney

NamePaul C. Llewellyn

Law firm

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP

Docket

1101804.0002

Address

250 WEST 55TH STREET, NEW YORK, NY 10019-9710, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateAug 24, 2018

Serial Number88091437

Registration No.0

Status DateAug 01, 2022

Published for OppositionApr 30, 2019

Mark TypeStandard characters

Attorney Docket1101804.0002

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 041Education & entertainment services

US codes: 100, 101, 107

Education; providing of training; entertainment; sporting and cultural activities.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

48 events

ABANDONMENT - NO USE STATEMENT FILED

Aug 01, 2022

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 01, 2022

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

CORRECTED NOA E-MAILED

May 17, 2022

CORRECTED NOA E-MAILED

DIVISIONAL PROCESSING COMPLETE

May 16, 2022

DIVISIONAL PROCESSING COMPLETE

TEAS REQUEST TO DIVIDE RECEIVED

Mar 07, 2022

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

Mar 07, 2022

DIVISIONAL REQUEST RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 30, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

Nov 29, 2021

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Nov 18, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Nov 18, 2021

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 30, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 28, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Apr 28, 2021

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Apr 28, 2021

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 18, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 16, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Nov 16, 2020

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Nov 16, 2020

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 29, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 27, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

May 27, 2020

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

May 27, 2020

SOU EXTENSION 2 GRANTED

CORRECTED NOA E-MAILED

Jan 15, 2020

CORRECTED NOA E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 15, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

DIVISIONAL PROCESSING COMPLETE

Jan 14, 2020

DIVISIONAL PROCESSING COMPLETE

SOU EXTENSION 1 GRANTED

Jan 14, 2020

SOU EXTENSION 1 GRANTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 20, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 10, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

Dec 10, 2019

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

SOU TEAS EXTENSION RECEIVED

Dec 06, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 06, 2019

SOU EXTENSION 1 FILED

TEAS REQUEST TO DIVIDE RECEIVED

Dec 05, 2019

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

Dec 05, 2019

DIVISIONAL REQUEST RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 25, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 30, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 30, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 10, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Mar 22, 2019

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 28, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 14, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 13, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 13, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

PRIORITY ACTION WRITTEN

Dec 13, 2018

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

Dec 13, 2018

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

Dec 13, 2018

NOTIFICATION OF PRIORITY ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 10, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 04, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 28, 2018

NEW APPLICATION ENTERED

AVERITAS PHARMA

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Averitas Pharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Paul C. Llewellyn

Resources

Company